These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22910222)

  • 1. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
    Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
    Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
    Jeon SY; Park JS; Yang HN; Woo DG; Park KH
    Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles.
    Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JH; Park KH
    Biomaterials; 2011 May; 32(14):3679-88. PubMed ID: 21333351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis.
    Kim JH; Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JM; Park KH
    Biomaterials; 2011 Jan; 32(1):268-78. PubMed ID: 20875683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilineage differentiation of human-derived dermal fibroblasts transfected with genes coated on PLGA nanoparticles plus growth factors.
    Park JS; Yang HN; Woo DG; Jeon SY; Park KH
    Biomaterials; 2013 Jan; 34(2):582-97. PubMed ID: 23092860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric nanoparticles for siRNA delivery and gene silencing.
    Patil Y; Panyam J
    Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles.
    Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS
    J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
    Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
    Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of RNAi on cyclooxygenase-2 expression and biologic activity of human rheumatoid arthritis synovial fibroblasts].
    Jiang LD; Wang HZ; Zhao FD; Guo JS; Bao CD; Zou HJ; Wang JY
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2925-8. PubMed ID: 18261308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.
    te Boekhorst BC; Jensen LB; Colombo S; Varkouhi AK; Schiffelers RM; Lammers T; Storm G; Nielsen HM; Strijkers GJ; Foged C; Nicolay K
    J Control Release; 2012 Aug; 161(3):772-80. PubMed ID: 22580113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
    Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
    Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein using PLGA nanoparticles to induce chondrogenesis of human mesenchymal stem cells.
    Jeon SY; Park JS; Yang HN; Lim HJ; Yi SW; Park H; Park KH
    Biomaterials; 2014 Sep; 35(28):8236-48. PubMed ID: 24965885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.
    Présumey J; Salzano G; Courties G; Shires M; Ponchel F; Jorgensen C; Apparailly F; De Rosa G
    Eur J Pharm Biopharm; 2012 Nov; 82(3):457-64. PubMed ID: 22922428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X; Shah BA; Kotadia NK; Li J; Gu H; Wu Z
    Pharm Res; 2010 Jul; 27(7):1285-95. PubMed ID: 20309616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.